Skye Bioscience, Inc. Interest Expense
Skye Bioscience, Inc. (SKYE) reported Interest Expense of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2026-03-10
- Skye Bioscience, Inc. interest expense for the quarter ending 2024-03-31 was $436.94K, a 2275.17% increase year-over-year.
- Skye Bioscience, Inc. interest expense for the quarter ending 2023-12-31 was $430.13K, a 767.73% increase year-over-year.
- Skye Bioscience, Inc. interest expense for the quarter ending 2023-09-30 was $271.31K, a 28.44% increase year-over-year.
- Skye Bioscience, Inc. interest expense for the quarter ending 2023-06-30 was $186.43K, a 9.19% decline year-over-year.
- Skye Bioscience, Inc. interest expense for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Skye Bioscience, Inc. interest expense for fiscal 2024 was $749.31K, a 17.32% decline from fiscal 2023.
- Skye Bioscience, Inc. interest expense for fiscal 2023 was $906.27K, a 36.25% increase from fiscal 2022.
- Skye Bioscience, Inc. interest expense for fiscal 2022 was $665.13K, a 13.52% decline from fiscal 2021.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month | Interest Expense 25 month | Interest Expense 29 month |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-10 | ||||||||
| 2024-12-31 | $749.31K 10-K · filed 2026-03-10 | ||||||||
| 2024-03-31 | $436.94K 10-Q · filed 2024-05-10 | $867.07K derived: sum of 2 quarters · filed 2025-03-20 | $1.14M derived: sum of 3 quarters · filed 2025-03-20 | $1.32M derived: sum of 4 quarters · filed 2025-03-20 | |||||
| 2023-12-31 | $430.13K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $701.44K derived: sum of 2 quarters · filed 2025-03-20 | $887.87K derived: sum of 3 quarters · filed 2025-03-20 | $906.27K 10-K · filed 2025-03-20 | |||||
| 2023-09-30 | $271.31K 10-Q · filed 2023-11-14 | $457.74K derived: sum of 2 quarters · filed 2023-11-14 | $476.13K 10-Q · filed 2023-11-14 | $525.70K derived: sum of 4 quarters · filed 2024-05-10 | |||||
| 2023-06-30 | $186.43K 10-Q · filed 2023-08-07 | $204.83K 10-Q · filed 2023-08-07 | $254.40K derived: sum of 3 quarters · filed 2024-05-10 | $465.62K derived: sum of 4 quarters · filed 2024-05-10 | |||||
| 2023-03-31 | $18.40K 10-Q · filed 2024-05-10 | $18.40K 10-Q · filed 2023-05-12 | $67.97K derived: sum of 2 quarters · filed 2024-05-10 | $279.19K derived: sum of 3 quarters · filed 2024-05-10 | $484.50K derived: sum of 4 quarters · filed 2024-05-10 | ||||
| 2022-12-31 | $49.57K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $260.80K derived: sum of 2 quarters · filed 2024-03-22 | $466.10K derived: sum of 3 quarters · filed 2024-03-22 | $665.13K 10-K · filed 2024-03-22 | |||||
| 2022-09-30 | $211.23K 10-Q · filed 2023-11-14 | $416.53K derived: sum of 2 quarters · filed 2023-11-14 | $615.56K 10-Q · filed 2023-11-14 | $814.40K derived: sum of 4 quarters · filed 2023-11-14 | |||||
| 2022-06-30 | $205.30K 10-Q · filed 2023-08-07 | $404.33K 10-Q · filed 2023-08-07 | $603.17K derived: sum of 3 quarters · filed 2023-08-07 | $798.53K derived: sum of 4 quarters · filed 2023-08-07 | |||||
| 2022-03-31 | $199.03K 10-Q · filed 2023-05-12 | $397.87K derived: sum of 2 quarters · filed 2023-05-12 | $593.23K derived: sum of 3 quarters · filed 2023-05-12 | $783.29K derived: sum of 4 quarters · filed 2023-05-12 | |||||
| 2021-12-31 | $198.84K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $394.19K derived: sum of 2 quarters · filed 2023-03-31 | $584.25K derived: sum of 3 quarters · filed 2023-03-31 | $769.16K 10-K · filed 2023-03-31 | |||||
| 2021-09-30 | $195.36K 10-Q · filed 2022-11-14 | $385.42K derived: sum of 2 quarters · filed 2022-11-14 | $570.32K 10-Q · filed 2022-11-14 | $756.11K derived: sum of 4 quarters · filed 2022-11-14 | |||||
| 2021-06-30 | $190.06K 10-Q · filed 2022-08-15 | $374.96K 10-Q · filed 2022-08-15 | $560.75K derived: sum of 3 quarters · filed 2022-08-15 | $743.37K derived: sum of 4 quarters · filed 2022-08-15 | |||||
| 2021-03-31 | $184.91K 10-Q · filed 2022-05-06 | $370.70K derived: sum of 2 quarters · filed 2022-05-06 | $553.31K derived: sum of 3 quarters · filed 2022-05-06 | $724.93K derived: sum of 4 quarters · filed 2022-05-06 | |||||
| 2020-12-31 | $185.79K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $368.40K derived: sum of 2 quarters · filed 2022-03-28 | $540.03K derived: sum of 3 quarters · filed 2022-03-28 | $706.38K 10-K · filed 2022-03-28 | |||||
| 2020-09-30 | $182.61K 10-Q · filed 2021-11-10 | $354.24K derived: sum of 2 quarters · filed 2021-11-10 | $520.59K 10-Q · filed 2021-11-10 | $809.73K derived: sum of 4 quarters · filed 2021-11-10 | |||||
| 2020-06-30 | $171.63K 10-Q · filed 2021-08-06 | $337.98K 10-Q · filed 2021-08-06 | $627.12K derived: sum of 3 quarters · filed 2021-08-06 | $928.66K derived: sum of 4 quarters · filed 2021-08-06 | |||||
| 2020-03-31 | $166.35K 10-Q · filed 2021-05-07 | $455.49K derived: sum of 2 quarters · filed 2021-05-07 | $757.04K derived: sum of 3 quarters · filed 2021-05-07 | $1.05M derived: sum of 4 quarters · filed 2021-05-07 | |||||
| 2019-12-31 | $289.14K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $590.68K derived: sum of 2 quarters · filed 2021-03-02 | $884.65K derived: sum of 3 quarters · filed 2021-03-02 | $1.00M 10-K · filed 2021-03-02 | |||||
| 2019-09-30 | $301.55K 10-Q · filed 2020-11-06 | $595.51K derived: sum of 2 quarters · filed 2020-11-06 | $711.58K 10-Q · filed 2020-11-06 | $768.63K derived: sum of 4 quarters · filed 2020-11-06 | |||||
| 2019-06-30 | $293.96K 10-Q · filed 2020-08-13 | $410.03K 10-Q · filed 2020-08-13 | $467.08K derived: sum of 3 quarters · filed 2020-08-13 | $467.08K derived: sum of 4 quarters · filed 2020-08-13 | |||||
| 2019-03-31 | $116.06K 10-Q · filed 2020-05-08 | $173.12K derived: sum of 2 quarters · filed 2020-05-08 | $173.12K derived: sum of 3 quarters · filed 2020-05-08 | $173.12K derived: sum of 4 quarters · filed 2020-05-08 | |||||
| 2018-12-31 | $57.05K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-23 | $57.05K derived: sum of 2 quarters · filed 2020-03-23 | $57.05K derived: sum of 3 quarters · filed 2020-03-23 | $94.76K 10-K · filed 2020-03-23 | |||||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-14 | $0.00 derived: sum of 2 quarters · filed 2019-11-14 | $37.71K 10-Q · filed 2019-11-14 | $3.10K 10-Q · filed 2018-11-14 | |||||
| 2018-06-30 | $0.00 10-Q · filed 2019-08-09 | $37.71K 10-Q · filed 2019-08-09 | $3.10K 10-Q · filed 2018-08-10 | ||||||
| 2018-03-31 | $37.71K 10-Q · filed 2019-05-10 | $3.10K 10-Q · filed 2018-05-15 | |||||||
| 2017-12-31 | $667.00 10-K · filed 2019-03-14 | ||||||||
| 2014-07-31 | $776.00 10-Q · filed 2014-09-15 | $1.08K derived: sum of 2 quarters · filed 2014-09-15 | $1.49K 10-Q · filed 2014-09-15 | $2.12K derived: sum of 4 quarters · filed 2014-09-15 | |||||
| 2014-04-30 | $307.00 10-Q · filed 2014-06-05 | $717.00 10-Q · filed 2014-06-05 | $1.34K derived: sum of 3 quarters · filed 2014-06-05 | $2.01K derived: sum of 4 quarters · filed 2014-09-15 | |||||
| 2014-01-31 | $410.00 10-Q · filed 2014-03-17 | $1.04K derived: sum of 2 quarters · filed 2014-03-17 | $1.70K derived: sum of 3 quarters · filed 2014-09-15 | $2.35K derived: sum of 4 quarters · filed 2014-09-15 | |||||
| 2013-10-31 | $628.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-01-27 | $1.29K derived: sum of 2 quarters · filed 2014-09-15 | $1.94K derived: sum of 3 quarters · filed 2014-09-15 | $2.15K 10-K · filed 2014-01-27 | |||||
| 2013-07-31 | $662.00 10-Q · filed 2014-09-15 | $1.31K derived: sum of 2 quarters · filed 2014-09-15 | $1.52K 10-Q · filed 2014-09-15 | $1.52K 10-Q · filed 2013-09-16 | |||||
| 2013-04-30 | $649.00 10-Q · filed 2014-06-05 | $862.00 10-Q · filed 2014-06-05 | $862.00 10-Q · filed 2013-06-27 | ||||||
| 2013-01-31 | $213.00 10-Q · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |